| Followers | 186 |
| Posts | 19156 |
| Boards Moderated | 0 |
| Alias Born | 10/14/2009 |
Wednesday, July 03, 2013 9:15:55 AM
BISU product on line..VERY_SOON!!.Must..Read! NFL..endorsement
Nice for shareholders here very soon$ Multi-bagger
BISU youtube >>Products<<Niceeeeee>
better video coming... product with partner 500 niceee
Ab$
BISU THIS YEAR WILL BE A LANDMARK YEAR FOR_TYPE 2 DEFENSE
http://www.biosolutionscorp.com/blog/this-year-will-be-a-landmark-year-for-type-2-defense/
BISU PROFITS AND DEALS We have been hard at work for the past four weeks and it looks like we are about ready to make our big move. Our Type 2 Defense product is in full production mode and the roll out is set to begin early next month. This diabetes product has a huge market and healthy margins. We intend to have an aggressive online marketing campaign with this product as the focal point. The sales effort will be anchored by endorsements from some of the professional athletes we are talking with at this time. Having the endorsement of MLB, NFL and NHL: players will create organic visibility for the product launch. The generous margins for Type 2 Defense will allow the company to become cash flow positive very quickly. A successful Type 2 Defense launch will be a template for other products in our pipeline.
Our shareholders can also expect to see some acquisition news, shortly. The company has been investigating many natural remedy opportunities including some in the medical marijuana space. The medical marijuana opportunities offered to the company have significant upside so makinga decision is not a simple as it would seem. The variety of these projects has led to a longer than expected due diligence period but we are winding this process down and we think we will be a in a position to make an announcement very soon. Management is focused on insuring that the new opportunities are in sync with the focus on natural remedies and have the same margin profile as our primary product.
RELATED POSTS
http://www.biosolutionscorp.com/blog/bisu-in-a-multi-billion-dollar-market-and-looking-at-another/
BISU.MEDICAL MARIJUANA COULD BE THE_PATH_TO_WELLNESS_AND_PROSPERITY
http://www.biosolutionscorp.com/blog/medical-marijuana-could-be-the-path-to-wellness-and-prosperity/
BISU IN A MULTI BILLION-DOLLAR_MARKET-AND_LOOKING_AT ANOTHER
http://www.biosolutionscorp.com/blog/bisu-in-a-multi-billion-dollar-market-and-looking-at-another/
Nice for shareholders here very soon$ Multi-bagger
BISU youtube >>Products<<Niceeeeee>
better video coming... product with partner 500 niceee
Ab$
BISU THIS YEAR WILL BE A LANDMARK YEAR FOR_TYPE 2 DEFENSE
http://www.biosolutionscorp.com/blog/this-year-will-be-a-landmark-year-for-type-2-defense/
BISU PROFITS AND DEALS We have been hard at work for the past four weeks and it looks like we are about ready to make our big move. Our Type 2 Defense product is in full production mode and the roll out is set to begin early next month. This diabetes product has a huge market and healthy margins. We intend to have an aggressive online marketing campaign with this product as the focal point. The sales effort will be anchored by endorsements from some of the professional athletes we are talking with at this time. Having the endorsement of MLB, NFL and NHL: players will create organic visibility for the product launch. The generous margins for Type 2 Defense will allow the company to become cash flow positive very quickly. A successful Type 2 Defense launch will be a template for other products in our pipeline.
Our shareholders can also expect to see some acquisition news, shortly. The company has been investigating many natural remedy opportunities including some in the medical marijuana space. The medical marijuana opportunities offered to the company have significant upside so makinga decision is not a simple as it would seem. The variety of these projects has led to a longer than expected due diligence period but we are winding this process down and we think we will be a in a position to make an announcement very soon. Management is focused on insuring that the new opportunities are in sync with the focus on natural remedies and have the same margin profile as our primary product.
RELATED POSTS
http://www.biosolutionscorp.com/blog/bisu-in-a-multi-billion-dollar-market-and-looking-at-another/
BISU.MEDICAL MARIJUANA COULD BE THE_PATH_TO_WELLNESS_AND_PROSPERITY
http://www.biosolutionscorp.com/blog/medical-marijuana-could-be-the-path-to-wellness-and-prosperity/
BISU IN A MULTI BILLION-DOLLAR_MARKET-AND_LOOKING_AT ANOTHER
http://www.biosolutionscorp.com/blog/bisu-in-a-multi-billion-dollar-market-and-looking-at-another/
Take a good decision for you !!
The magority of the pinks are scam
Recent GLUC News
- Glucose Health Expands Retail Distribution to 2,500+ Stores, Launches National Advertising Campaign • GlobeNewswire Inc. • 03/04/2026 12:30:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/04/2026 09:27:59 PM
- Glucose Health, Inc. Reports Debt-Free Balance Sheet and Previews New Soluble Fiber Brand • GlobeNewswire Inc. • 01/14/2026 12:15:00 PM
- Glucose Health, Inc. Board Members Confirm Participation in Preferred Share Conversion at 85% Premium to Market and Introduce New Revenue Growth Strategy • GlobeNewswire Inc. • 01/07/2026 12:15:00 PM
- Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth • GlobeNewswire Inc. • 12/23/2025 12:15:00 PM
- Glucose Health, Inc. Appoints Strategic Investor Christopher J. Jemapete to Its Board of Directors • GlobeNewswire Inc. • 10/29/2025 12:00:00 PM
- Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors • GlobeNewswire Inc. • 10/27/2025 12:00:00 PM
- Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors • GlobeNewswire Inc. • 10/23/2025 12:00:00 PM
- Glucose Health, Inc. (OTC: GLUC) Announces New Management Appointments and Strategic Outlook • GlobeNewswire Inc. • 10/21/2025 12:00:00 PM
- Glucose Health, Inc. Announces Officer Changes Effective September 30, 2025 • GlobeNewswire Inc. • 09/26/2025 08:00:00 PM
